The present invention relates generally to a method of treating infectious conjunctivitis by administering to an infected eye of a subject a composition comprising povidone-iodine and an excipient that reduces the ocular toxicity of the composition, wherein the composition does not include a steroidal anti-inflammatory drug or a non-steroidal anti-inflammatory drug.

Ophthalmic compositions for administration to an eye including a mixture of an antiseptic and an anesthetic in therapeutically effective amounts are disclosed. The compositions are both anesthetic and antiseptic, and can be used in various ophthalmic procedures.

Ophthalmic compositions for administration to an eye including a mixture of an antiseptic and an anesthetic in therapeutically effective amounts are disclosed. The compositions are both anesthetic and antiseptic, and can be used in various ophthalmic procedures.

A bactericidal composition comprising a carboxy group-containing cellulose ester or carboxy group-containing cellulose ether, a bactericide, alcohol, and water. Some embodiments further comprise a plasticizer. The compositions described herein may be used to disinfect the surface of skin in preparation for surgical procedures.

A bactericidal composition comprising a carboxy group-containing cellulose ester or carboxy group-containing cellulose ether, a bactericide, alcohol, and water. Some embodiments further comprise a plasticizer. The compositions described herein may be used to disinfect the surface of skin in preparation for surgical procedures.

Novel antimicrobial compositions and kits thereof containing these antimicrobial compositions, methods of manufacture and methods of use thereof are disclosed. The novel aqueous transdermal or topical delivery systems are useful, inter alia, for treatment of various microbial infections, including for use on tissue infections, particularly skin antisepsis and/or nasal mucosal tissue antisepsis to a mammalian host in need thereof.

Novel antimicrobial compositions and kits thereof containing these antimicrobial compositions, methods of manufacture and methods of use thereof are disclosed. The novel aqueous transdermal or topical delivery systems are useful, inter alia, for treatment of various microbial infections, including for use on tissue infections, particularly skin antisepsis and/or nasal mucosal tissue antisepsis to a mammalian host in need thereof.

Disclosed herein are compositions and methods for preventing or treating acute or chronic oral mucositis, esophagitis, enteritis, colitis, or gastrointestinal acute radiation syndrome (GI-ARS) caused by radiation exposure, using one or more enteron sorbent polymers administered gastrointestinally (e.g. orally, via feeding or gastric tube, via ostomy, or rectally).

The present invention provides aqueous formulations containing an anti-infection agent, a biocompatible polysaccharide, an osmotic pressure regulator, a pH regulator, and water, wherein a gel containing the therapeutic agent is formed in situ upon instillation of the formulations onto the skin and a body cavity of a subject. The formulations of this invention are useful for treating infectious diseases of skin or a body cavity (e.g., eye, nose, or vagina) of a subject.

The present invention provides aqueous formulations containing an anti-infection agent, a biocompatible polysaccharide, an osmotic pressure regulator, a pH regulator, and water, wherein a gel containing the therapeutic agent is formed in situ upon instillation of the formulations onto the skin and a body cavity of a subject. The formulations of this invention are useful for treating infectious diseases of skin or a body cavity (e.g., eye, nose, or vagina) of a subject.